Product Information
MELOXICAM 7.5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0168 per EA under NDC 69097015807. Its NADAC has been published 596 times since Jan 28, 2015.
Strength
7.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097015807
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA077929On Market Since
7/19/2006
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 7.5 MG TABLET has been published 596 times since Jan 28, 2015, and over the history we have for it it has declined 29.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0168 per EA |
|---|---|
| All-time high | $0.0255 (Apr 15, 2015) |
| All-time low | $0.0138 (Nov 20, 2024) |
| 52-week high | $0.0174 |
| 52-week low | $0.0164 |
| Median price | $0.0195 |
| Average price | $0.0197 |
| Largest weekly change | +26.2% (Aug 21, 2024) |
| Weeks tracked | 596 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MELOXICAM 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 7.5 MG TABLET, manufactured by Cipla USA Inc., is $0.0168 per EA (NDC 69097015807), effective Jun 24, 2026.
How has the price of MELOXICAM 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MELOXICAM 7.5 MG TABLET has declined 29.7%. It has been tracked across 596 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for MELOXICAM 7.5 MG TABLET?
Since Jan 28, 2015, the NADAC for MELOXICAM 7.5 MG TABLET has ranged from a low of $0.0138 (Nov 20, 2024) to a high of $0.0255 (Apr 15, 2015), with a median of $0.0195 per EA.
Are there cheaper alternatives to MELOXICAM 7.5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as MELOXICAM 7.5 MG TABLET, but none are currently priced below it.
Who manufactures MELOXICAM 7.5 MG TABLET?
MELOXICAM 7.5 MG TABLET (NDC 69097015807) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification